Evidence map›Paper›PMID 41008788›Full record

ArticleCancers2025

Cancer Growth and Invasion Are Increased in the Tight Skin (TSK) Mouse.

Maria Sol Recouvreux, Barbie Taylor-Harding, Amy C Rowat, Beth Y Karlan, Sandra Orsulic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria Sol RecouvreuxDepartment of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID 0000-0002-8064-9381
Barbie Taylor-HardingDepartment of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Amy C RowatDepartment of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA 90095, USA.
Beth Y KarlanDepartment of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID 0000-0002-9451-2933
Sandra OrsulicDepartment of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID 0000-0001-5119-8721

Funding

Identifying novel targets for cancer using high throughput deformability screeningR21CA289090 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Amy C Rowat · 2025 to 2026
$405k
Re-purposing beta-blockers to improve chemotherapy responseR21CA245667 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROWAT, AMY C · 2021 to 2022
$397k
BLRD VA I01 BX006020NCI NIH HHS R21 CA245667NCI NIH HHS R21 CA289090United States Department of Defense HT94252410193United States Department of Defense W81XWH2210631United States Department of Veterans Affairs BX006020
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CAFcancer-associated fibroblastscancer invasioncancer promotiondesmoplasiaFBN1fibrillinhost response to cancermyofibroblastssclerodermasystemic sclerosis

Identifiers

PMID41008788
PMCPMC12468543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.